Effects on Insulin Resistance and Metabolic Markers A separate observational study of 56 women with PCOS and obesity treated with tirzepatide found: Significant weight reduction of 9.54% (p = 0.0004) Insulin resistance improved significantly: 80.4% of participants had insulin resistance at baseline
Zhang J, Xian TZ, Wu MX, Li C, Pan Q, Guo LX
15 mg of tirzepatide equals 75 units at a concentration of 20 mg/mL, or 50 units at a concentration of 30 mg/mL
Description Introducing Retatrutide 5mg from SSP Research, a novel multi-receptor peptide currently under investigation for its potential to influence weight management, glucose regulation, and metabolic resilience
Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014
3 Biotech (2021) 11(4):179